Antibody data
- Antibody Data
- Antigen structure
- References [12]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB2588 - Provider product page
- Provider
- Novus Biologicals
- Product name
- Rat Monoclonal ULBP-1 Antibody
- Antibody type
- Monoclonal
- Description
- Protein A or G purified from hybridoma culture supernatant. Detects mouse ULBP-1/MULT-1.
- Reactivity
- Mouse
- Host
- Rat
- Isotype
- IgG
- Vial size
- 100 ug
- Concentration
- LYOPH
- Storage
- Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Submitted references Natural killer cells impede the engraftment of cardiomyocytes derived from induced pluripotent stem cells in syngeneic mouse model.
Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.
Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.
NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry.
Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound repair.
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation.
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.
Nakamura Y, Miyagawa S, Yoshida S, Sasawatari S, Toyofuku T, Toda K, Sawa Y
Scientific reports 2019 Jul 25;9(1):10840
Scientific reports 2019 Jul 25;9(1):10840
Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.
Ma L, Han M, Keyoumu Z, Wang H, Keyoumu S
Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 25;23:1980-1991
Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 25;23:1980-1991
Immunotherapy of Dual-Function Vector with Both Immunostimulatory and B-Cell Lymphoma 2 (Bcl-2)-Silencing Effects on Gastric Carcinoma.
Ma L, Han M, Keyoumu Z, Wang H, Keyoumu S
Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 25;23:1980-1991
Medical science monitor : international medical journal of experimental and clinical research 2017 Apr 25;23:1980-1991
NKp46+ Innate Lymphoid Cells Dampen Vaginal CD8 T Cell Responses following Local Immunization with a Cholera Toxin-Based Vaccine.
Luci C, Bekri S, Bihl F, Pini J, Bourdely P, Nouhen K, Malgogne A, Walzer T, Braud VM, Anjuère F
PloS one 2015;10(12):e0143224
PloS one 2015;10(12):e0143224
NKG2D-dependent activation of dendritic epidermal T cells in contact hypersensitivity.
Nielsen MM, Dyring-Andersen B, Schmidt JD, Witherden D, Lovato P, Woetmann A, Ødum N, Poulsen SS, Havran WL, Geisler C, Bonefeld CM
The Journal of investigative dermatology 2015 May;135(5):1311-1319
The Journal of investigative dermatology 2015 May;135(5):1311-1319
MULT1E/mIL-12: a novel bifunctional protein for natural killer cell activation.
Tietje A, Li J, Yu X, Wei Y
Gene therapy 2014 May;21(5):468-75
Gene therapy 2014 May;21(5):468-75
The E3 ligase Cbl-b and TAM receptors regulate cancer metastasis via natural killer cells.
Paolino M, Choidas A, Wallner S, Pranjic B, Uribesalgo I, Loeser S, Jamieson AM, Langdon WY, Ikeda F, Fededa JP, Cronin SJ, Nitsch R, Schultz-Fademrecht C, Eickhoff J, Menninger S, Unger A, Torka R, Gruber T, Hinterleitner R, Baier G, Wolf D, Ullrich A, Klebl BM, Penninger JM
Nature 2014 Mar 27;507(7493):508-12
Nature 2014 Mar 27;507(7493):508-12
RAE-1 ligands for the NKG2D receptor are regulated by E2F transcription factors, which control cell cycle entry.
Jung H, Hsiung B, Pestal K, Procyk E, Raulet DH
The Journal of experimental medicine 2012 Dec 17;209(13):2409-22
The Journal of experimental medicine 2012 Dec 17;209(13):2409-22
Involvement of an NKG2D ligand H60c in epidermal dendritic T cell-mediated wound repair.
Yoshida S, Mohamed RH, Kajikawa M, Koizumi J, Tanaka M, Fugo K, Otsuka N, Maenaka K, Yagita H, Chiba H, Kasahara M
Journal of immunology (Baltimore, Md. : 1950) 2012 Apr 15;188(8):3972-9
Journal of immunology (Baltimore, Md. : 1950) 2012 Apr 15;188(8):3972-9
Bortezomib treatment and regulatory T-cell depletion enhance the antitumor effects of adoptively infused NK cells.
Lundqvist A, Yokoyama H, Smith A, Berg M, Childs R
Blood 2009 Jun 11;113(24):6120-7
Blood 2009 Jun 11;113(24):6120-7
Tumor cells expressing a fusion protein of MULT1 and Fas are rejected in vivo by apoptosis and NK cell activation.
Kotturi HS, Li J, Branham-O'Connor M, Stickel SL, Yu X, Wagner TE, Wei Y
Gene therapy 2008 Oct;15(19):1302-10
Gene therapy 2008 Oct;15(19):1302-10
Blockade of NKG2D on NKT cells prevents hepatitis and the acute immune response to hepatitis B virus.
Vilarinho S, Ogasawara K, Nishimura S, Lanier LL, Baron JL
Proceedings of the National Academy of Sciences of the United States of America 2007 Nov 13;104(46):18187-92
Proceedings of the National Academy of Sciences of the United States of America 2007 Nov 13;104(46):18187-92
No comments: Submit comment
No validations: Submit validation data